Hepatitis C Treatment in Underserved Populations

Status unconfirmed · Not applicable

Conditions studied: Chronic Hepatitis C, Illicit Drug Use

In brief

The purpose of this study is to examine the feasibility, safety, and effectiveness of treating persons who are actively using illicit drugs for hepatitis C using a collaborative, multidisciplinary, integrated care model. We hypothesize that by maximizing facilitators and minimizing barriers to treatment we can enable drug users to receive effective treatment for hepatitis C.

Key facts

Study ID

NCT01717560

Run by

Brian Edlin

People needed

30

Starts

2005-02-01

Expected to finish

2020-12-01

Last updated by the study team

2012-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Used heroin, cocaine, or injected other drugs for at least 1 year
• Have used heroin, cocaine and/or methamphetamine within the last 30 days
• Test positive for HCV antibody
• Are interested in being evaluated for HCV treatment

You may not qualify if…

• Persons who are obviously intoxicated, incoherent or otherwise unable to give informed consent are excluded from participation. Such persons may participate in the study if they return at a later date and are capable of providing informed consent.

Where it is running

• Center for the Study of Hepatitis C, Weill Medical College, Cornell University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.